STAFFORD HEALTH AND WELLBEING
WHITGREAVE COURT, STAFFORD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 11 | 15 | 73.3% | |
| HF 4 | 2011 | 11 | 13 | 84.6% | |
| HF 4 | 2012 | 12 | 18 | 66.7% | |
| HF 4 | 2013 | 15 | 20 | 75.0% | |
| HF004 | 2014 | 17 | 22 | 77.3% | |
| HF004 | 2015 | 17 | 21 | 81.0% | |
| HF004 | 2016 | 20 | 23 | 87.0% | |
| HF004 | 2017 | 21 | 22 | 95.5% | |
| HF004 | 2018 | 50 | 60 | 83.3% | |
| HF004 | 2019 | 50 | 63 | 79.4% | |
| HF004 | 2020 | 43 | 52 | 82.7% | |
| HF006 | 2021 | 51 | 54 | 94.4% | |
| HF006 | 2022 | 53 | 61 | 86.9% | |
| HF006 | 2023 | 47 | 53 | 88.7% |
